Bonafi
Compliant. Traceable. Transparent.
Industry Insights
Industry Feed
- Ph. Eur. Cannabis Monograph Proposed for Comment
- Revised Ph. Eur. Chapter on Rubber Closures
- Warning Letter to US Manufacturer of Sterile Medicinal Products - Part 1
- Reverse Osmosis in Pharmaceutical Water - How often to sanitise?
- Is there a Specification for the Ozone Concentration in hot or cold stored Pharmaceutical Water Systems
- Breakthrough Device Programme of the FDA
- New Article on CDRH Learn
- Risk Management Plans to Mitigate Drug Shortages also affect Medical Devices
- Regulatory information – adjusted fees for pharmacovigilance applications from 3 October 2022, , 30/09/2022
Pharmacovigilance fees payable to the European Medicines Agency by applicants and marketing authorisation holders increase by 5.6% as of 3 October 2022,...
- New recommendations for terlipressin-containing medicines in the treatment of hepatorenal syndrome, PRAC, 30/09/2022
EMA’s safety committee (PRAC) recommended new measures to reduce the risk of respiratory failure (severe breathing difficulties that may be life-...
Interested in learning more?
If you would like to see a demo, interested in our Beta Programme or would like to find out more information, we are happy to help.
FIND US
NEWS
© 2022 Bonafi. All rights reserved.